Efficacy and Safety of Luseogliflozin in Patient With Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
figureposted on 15.02.2021, 13:19 by Adis journals on behalf of, Hiroaki Seino
Article full text
The above summary slide represents the opinions of the author. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.